Lakai Enterline, DO
Orthopaedic Surgery · Garden City, MINPI 1922459452
Payments from drug & device makers
What this record shows
This record is dominated by education: $14,315 of the $16,482 with a category attached, or 86.9%. Smith+Nephew accounts for 65.7% of it on its own, with 15 other manufacturers making up the rest. Reporting peaked in 2022 at $8,521 and has fallen 93.4% since, to $563 in 2025.
Across 39 payments — averaging $422.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$11K
- Arthrex$2K
- Pinnacle, Inc$1K
- Zimmer Biomet$1K
- Stryker$205
- Xiros Inc$173
- plus $579 from 10 others
What the payments were for
- Travel & lodging$1281%
- Food & beverage$2,03912%
- Education$14,31587%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 10 | $10,830 |
| Arthrex | 2 | $2,400 |
| Pinnacle, Inc | 3 | $1,248 |
| Zimmer Biomet | 6 | $1,047 |
| Stryker | 3 | $205 |
| Xiros Inc | 2 | $173 |
| Baxter Healthcare | 1 | $115 |
| Johnson & Johnson | 1 | $107 |
| Medacta USA, Inc. | 1 | $93 |
| Heron Therapeutics, Inc. | 1 | $83 |
| Ferring Pharmaceuticals Inc. | 3 | $47 |
| Vericel Corporation | 2 | $41 |
| Wardlow Enterprises | 1 | $35 |
| MF MED | 1 | $27 |
| Orthofix Medical, Inc. | 1 | $15 |
| Bioventus LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Comprehensive Shoulder System$544
- Bone Anchors with Arthroscopic Delivery System$292
- Persona$171
- Bioinductive Implant with Arthroscopic Delivery System - Medium$153
- FAST-FIX$126
- ACUFEX Meniscal Root Repair$126
- NOVOSTITCH$126
- CHAMPION$125
- Juggerloc$120
- FLOSEAL$115
- Samples Biologics$108
- SCP Bone Substitute$108
- IM NAILS$107
How this compares
$16,482 in reported general payments places this provider in the 80th percentile of 829 orthopaedic surgery providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone Hcl | 41 | $172 |
| Meloxicam | 42 | $164 |
| Methylprednisolone | 18 | $112 |
| Diclofenac Sodium | 12 | $75 |
| Tramadol Hcl | 27 | $56 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Garden City
- Asheesh BediAnn Arbor$9.4M
- Jerome WiaterBeverly Hills$3.9M
- Mark PintoChelsea$3.2M
- Kyle AndersonBingham Farms$3.1M
- Stephen BartolDetroit$2.6M
- Jad KhalilSouthfield$1.9M
- Jeffrey FischgrundSouthfield$1.8M
- John BlahaAnn Arbor$1.5M
- David MarkelSouthfield$1.5M
- Christopher ChuinardTraverse City$1.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.